ACHE and dementia: In contrast, the STOPP Criteria highlight a potential DDI involving anti-dementia drugs, specifically donepezil (an acetylcholinesterase inhibitor) combined with bisoprolol (a beta-blocker known to cause persistent bradycardia), which can lead to cardiac conduction failure, syncope, and injury.